OpenVSafe by OpenVAERS
Search V-safe

BSN-24954-44318

2 vaccinations 3 coded responses 11 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
66+
ZIP prefix
201 / VA
Registered
2021-03-25
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-03
    Dose 1 — Moderna
  2. 2021-03-25
    Registered in v-safe
  3. 2021-03-25
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  4. 2021-03-31
    Health check-in — day 28, dose 1
    Feeling: Good
    Adult check-in
  5. 2021-04-01
    Dose 2 — Moderna
  6. 2021-04-07
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chills, Decreased appetite, Eructation, Fatigue, Headache, Injection site erythema, Injection site pain, Injection site pruritus, Injection site warmth, Pyrexia — Feeling: Good · Site: Pain, Redness, Itching · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: For Approximate ly 24 hours, I had significant symptoms, they started about 12-18 hours after receiving the vaccination. I had:1.chills, fever up to 100.7, great fatigue, anorexia, burping, mild headache, mild to moderate localized injection site pain redness and heat. Theses symptoms abruptly stopped 24hrs later. The injection site started itching 72 hours after injection and has continue for one week.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-04-08
    Survey response — day 7, dose 2
    MedDRA: Unevaluable event — Feeling: Good · Site: Itching
    Free text: Please read my previous report yesterday
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-04-15
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  9. 2021-04-22
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-04-29
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-05-06
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-05-13
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-10-02
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  14. 2022-02-05
  15. 2022-04-01
    Survey response — 12 months, dose 2
    MedDRA: Aortic arteriosclerosis, Endometrial thickening, Nephrolithiasis, Ureteral stent insertion — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Totally unrelated to COVID. Kidney stone + ureteral stent. Endometrial thickening, Atherosclerotic aortic patch
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-04-01
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    Emergency room or emergency department visit · 1 call case(s)

Vaccinations

DoseDateManufacturerCo-administered
12021-03-03Moderna
22021-04-01Moderna

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-07

Systemic reaction (other): For Approximate ly 24 hours, I had significant symptoms, they started about 12-18 hours after receiving the vaccination. I had:1.chills, fever up to 100.7, great fatigue, anorexia, burping, mild headache, mild to moderate localized injection site pain redness and heat. Theses symptoms abruptly stopped 24hrs later. The injection site started itching 72 hours after injection and has continue for one week.

Release 7 — day 7, dose 2

2021-04-08

Systemic reaction (other): Please read my previous report yesterday

Release 11 — 12 months, dose 2

2022-04-01

Symptoms: Totally unrelated to COVID. Kidney stone + ureteral stent. Endometrial thickening, Atherosclerotic aortic patch

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAortic arteriosclerosis · · ✓
SDEndometrial thickening · · ✓
SDNephrolithiasis · · ✓
SDUreteral stent insertion · · ✓
SROChills ✓ ✓ ✓
SRODecreased appetite ✓ ✓ ✓
SROEructation ✓ ✓ ✓
SROFatigue ✓ ✓ ✓
SROHeadache ✓ ✓ ✓
SROInjection site erythema ✓ ✓ ✓
SROInjection site pain ✓ ✓ ✓
SROInjection site pruritus ✓ ✓ ✓
SROInjection site warmth ✓ ✓ ✓
SROPyrexia ✓ ✓ ✓
SROUnevaluable event ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release